Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Accounting Policies, by Policy (Policies)
Notes Tables
Notes Details

COMMITMENTS

COMMITMENTS	9 Months Ended
Sep. 30, 2022
Commitments [Abstract]
COMMITMENTS	13.COMMITMENTS As of September 30, 2022, the Company is committed to payments totaling $13.3 million (December 31, 2021 - $9.3 million) for activities related to the development of the Enos system.

COMMITMENTS

9 Months Ended

Sep. 30, 2022

Commitments [Abstract]

COMMITMENTS

13.COMMITMENTS

As of September 30, 2022, the Company is committed to payments totaling $13.3 million (December 31, 2021 - $9.3 million) for activities related to the development of the Enos system.